1.
Need
Clinical
Disease State Characterization
50%
9/18/2020
9/18/2020
Clinical
Unmet Need Statement
100%
9/18/2020
9/18/2020
Market/Bus
Existing Solutions Characterized
100%
9/18/2020
9/18/2020
Market/Bus
Needs Screening and Selection
30%
9/18/2020
9/18/2020
Regulatory
Regulation familiarization
50%
9/18/2020
9/18/2020
Technology
State of the Art Summary
50%
9/18/2020
9/18/2020
2.
Idea
Clinical
Envisioned Benefit Statement
50%
9/18/2020
9/18/2020
Clinical
Feedback from 5+ Clinical Stakeholders
100%
9/18/2020
9/18/2020
Clinical
Updated Need Statement
0%
Clinical
Workflow Scenario
0%
Market/Bus
Competitive Landscape
10%
9/18/2020
9/18/2020
Market/Bus
Envisioned Value Proposition
30%
9/18/2020
9/18/2020
Market/Bus
Key stakeholders identified
30%
9/18/2020
9/18/2020
Market/Bus
Reimbursement Familiarization
30%
9/19/2020
9/19/2020
Regulatory
Comparables Identified
100%
9/18/2020
9/18/2020
Regulatory
Intended Use and Medical Device Determination
100%
9/18/2020
9/18/2020
Technology
Idea Screening and Selection
100%
9/18/2020
9/18/2020
Technology
Institutional IP Disclosure
0%
Technology
Interface Mock-Ups
100%
9/18/2020
9/18/2020
Technology
System and Module Requirement Specification
100%
9/18/2020
9/18/2020
3.
Proof of Concept
Clinical
Feedback from Clinical Stakeholders in 5+ settings
0%
Clinical
Target Outcomes
0%
Clinical
Updated Need Statement and Workflow Scenario
0%
Market/Bus
Business Protection Model
0%
Market/Bus
Competing Solutions Characterization
0%
Market/Bus
Preliminary Path-to-Payment Plan
0%
Market/Bus
Preliminary Value Proposition
0%
Market/Bus
Stakeholder Map
0%
Regulatory
Preliminary Indications for Use
0%
Regulatory
Preliminary Regulatory Classification and Pathway
70%
9/18/2020
9/18/2020
Regulatory
Preliminary Risk and Hazard Analysis
0%
Technology
Demonstration Results
100%
9/18/2020
9/18/2020
Technology
Key In-Sourcing Requirements
30%
9/18/2020
9/18/2020
Technology
Key Module PoC Prototypes
100%
9/18/2020
9/18/2020
Technology
Preliminary System and Software Architecture
100%
9/19/2020
9/19/2020
Technology
Updated Institutional IP Disclosure
0%
4.
Proof of Feasibility
Clinical
Feedback from Clinical Stakeholders in 20+ Settings
0%
Clinical
Updated Need and Workflow Descriptions
0%
Clinical
Updated Target Outcomes
0%
Market/Bus
Business Advisory Board
0%
Market/Bus
Development Plan
0%
Market/Bus
Feedback from 5+ Economic Buyers
0%
Market/Bus
Key Relationships Identified
0%
Market/Bus
Preliminary Business Model
0%
Market/Bus
Secure Access to Core IP
0%
Regulatory
Cyber Security Plan
0%
Regulatory
Draft Essential Requirements Checklist
0%
Regulatory
Draft Instructions For Use
0%
Regulatory
Draft Product Claims
0%
Regulatory
Institutional Approval Request(s)
0%
Regulatory
Submission Pathway Defined
0%
Technology
Essential Experiment Results
100%
9/19/2020
9/19/2020
Technology
Key In-Sourcing plans
50%
9/19/2020
9/19/2020
Technology
Product Requirement Document (PRD)
0%
Technology
Provisional IP filing & initial FTO review
0%
Technology
Risk Mitigation and Interoperability Plan
70%
9/19/2020
9/19/2020
Technology
Software and Hardware Architecture
90%
9/19/2020
9/19/2020
Technology
Works-Like Prototypes
100%
9/19/2020
9/19/2020
5.
Proof of Value
Clinical
Clinical Pilot
0%
Clinical
Clinical Trial Endpoints
0%
Clinical
Feedback from 100+ Clinical Stakeholders
0%
Clinical
Feedback from 5+ KOLs
0%
Clinical
Medical Advisory Board
0%
Market/Bus
Feedback from 10+ Economic Buyers
0%
Market/Bus
Incorporation and Founders Agreement
0%
Market/Bus
Initial seed investment
0%
Market/Bus
Investor Ready Business Plan
0%
Market/Bus
Key Management Team Committed
0%
Market/Bus
Key Relationships Formalized
0%
Regulatory
Application to Regulatory Authority Submitted
0%
Regulatory
Clinical Investigation Approval(s)
0%
Regulatory
Electronic Protected Health Information (ePHI) Plans
0%
Regulatory
Essential Requirements Checklist
0%
Technology
cGMPs Medical Software and Production Environment(s)
0%
Technology
Essential Technical Experiments Results
0%
Technology
Interoperability Validation
0%
Technology
IP search report
0%
Technology
Key In-Sourcing Requirements Committed
0%
Technology
Works-Like-Looks-Like prototypes
0%
6.
Initial Clinical Trials
Clinical
Demo Feedback From 20+ Clinical Stakeholders
0%
Clinical
Endpoints Achieved in Feasibility Clinical Trials
0%
Clinical
Peer Reviewed Publication(s) Submitted
0%
Market/Bus
1st Institutional investment
0%
Market/Bus
Feedback from 20+ Economic Buyers
0%
Market/Bus
Validated Quantification
0%
Regulatory
Data Requirements Confirmation
0%
Regulatory
GDPR-HIPAA Compliance
0%
Regulatory
Pre-Submission Filed
0%
Regulatory
Security and Vulnerability Certifications
0%
Technology
All In-Sourcing Requirements Achieved
0%
Technology
Full IP Application
0%
Technology
Updated specification & experimental validation
0%
7.
Validation of Solution
Clinical
Endpoints Achieved in Pivotal Clinical Trials
0%
Clinical
Peer Reviewed Publication(s) Accepted
0%
Market/Bus
2nd Round of Institutional Investment
0%
Market/Bus
Purchasing Intent From 10+ Buyers
0%
Regulatory
Submission of Technical File to Regulatory Body
0%
Technology
Quality Assured Process Validation (cGMP)
0%
Technology
Updated Specification and Experimental Validation
0%
8.
Approval & Launch
Clinical
Specialty Medical Group(s) Review in Place
0%
Clinical
Training Materials & Support Established
0%
Market/Bus
Initial Sales/ Deployment
0%
Market/Bus
Regionalization Plan
0%
Regulatory
Public Coverage and Code Determination
0%
Regulatory
Regulation and Listing
0%
Technology
Finalized cGMP Production Environment
0%
Technology
Regionalization Requirements
0%
9.
Clinical Use
Clinical
Included in local practice guidelines
0%
Clinical
Peer Reviewed Publication(s)
0%
Market/Bus
New Markets Launched
0%
Market/Bus
Profitable Sales
0%
Regulatory
Monitoring and Inspections
0%
Technology
Improvement Plan
0%
Technology
Regionalization Implemented
0%
10.
Standard of Care
Clinical
Recommended Practice by Medical Specialty
0%
Market/Bus
Dominant Market Share
0%
Market/Bus
Health Economics Study
0%
Regulatory
Product Obsolescence Plan
0%
Technology
Component Obsolescence Plan
0%